Softwr

Healthcare · head to head

Allscripts vs Annalise.ai

Allscripts logo

Allscripts

Healthcare

Healthcare IT solutions for care coordination

From
On request
Rated
-
Full reviewWebsite
Annalise.ai logo

Annalise.ai

Healthcare

Multi-finding chest X-ray and head CT triage AI with FDA clearance on named findings, not on the whole model

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Allscripts pricing is not publicly available; all quotes require direct contact with sales; Annalise.ai the United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • They diverge on capability: Allscripts covers Electronic Health Records, Annalise.ai covers Annalise Enterprise CXR.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Allscripts and Annalise.ai actually diverge.

Attributes where Allscripts and Annalise.ai differ
AttributeAllscriptsAnnalise.ai
PlatformsWebWeb, Cloud, On-premise
Founded1986Unknown

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Allscripts

  • Electronic Health Records
  • Practice Management
  • Population Health
  • Care Coordination
  • Analytics
  • HL7
  • FHIR
  • Labs

Only in Annalise.ai

  • Annalise Enterprise CXR
  • Annalise Enterprise CTB
  • Triage and notification
  • Worklist reprioritisation
  • Localisation overlays
  • Confidence output
  • PACS-native deployment
  • On-premise or cloud inference

What people use each for

The jobs each tool is most often brought in to do.

Allscripts

  • Electronic health records and practice management for healthcare providersnot Annalise.ai
  • Healthcare IT solutions for revenue cycle management and patient engagement (now Veradigm)not Annalise.ai

Annalise.ai

  • An emergency department wanting pneumothorax and intracranial haemorrhage pushed to the front of the reading queue overnight when cover is thinnestnot Allscripts
  • A teleradiology provider covering many small hospitals that needs consistent triage before a human readsnot Allscripts
  • A screening programme in Europe where the broader CE marked decision support indication, rather than the narrow United States triage clearance, is what is being deployednot Allscripts
  • A radiology department building an AI governance programme that wants one vendor covering both chest radiograph and head CT rather than contracting two separate algorithm suppliersnot Allscripts

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Allscripts

  • Pricing is not publicly available; all quotes require direct contact with sales
  • Transitioned to Veradigm brand in 2022; legacy Allscripts product line integrated into Veradigm suite

Annalise.ai

  • The United States cleared indication covers roughly ten findings for triage and notification, far fewer than the model reports, so a buyer who evaluates the full multi-finding output and then contracts in the United States gets a much narrower cleared use.
  • Triage AI reprioritises a worklist but does not change clinical decisions on its own, so departments that do not redesign how urgent studies are picked up see no measurable improvement in time to treatment.
  • Published validation is largely reader study evidence on detection of individual findings; prospective evidence of shorter time to treatment in routine emergency care is thin.
  • The Annalise brand is being migrated under the Harrison.ai name for the critical care offering, which creates ambiguity in multi-year contracts about what product name is actually being supported.
  • A high finding count raises the alert burden, and departments report that low prevalence findings generate false positives that erode radiologist trust unless the alerting thresholds are tuned locally.

Pricing, plan by plan

Allscripts

On request

No published plan breakdown. See the Allscripts review.

Annalise.ai

On request
  • Annalise Enterprise$undefined/year
    • Priced per study analysed or as an annual volume subscription
    • CXR and CTB licensed separately
    • Cleared finding set differs by market, which changes what you are buying

Which should you pick?

Choose Allscripts if

  • You need electronic health records.
  • You also want practice management.
Allscripts review

Choose Annalise.ai if

  • You need annalise enterprise cxr.
  • You work on Web, Cloud, On-premise.
  • You also want annalise enterprise ctb.
Annalise.ai review

Questions people ask

Is Allscripts or Annalise.ai better?
Neither clearly leads. Allscripts starts at On request and Annalise.ai at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Allscripts or Annalise.ai?
Allscripts starts at On request and Annalise.ai at On request.
Does Allscripts or Annalise.ai run on more platforms?
Allscripts runs on Web. Annalise.ai runs on Web, Cloud, On-premise.
What is Allscripts best used for?
Allscripts is most often used for electronic health records and practice management for healthcare providers, healthcare it solutions for revenue cycle management and patient engagement (now veradigm). Of those, electronic health records and practice management for healthcare providers and healthcare it solutions for revenue cycle management and patient engagement (now veradigm) are not what Annalise.ai is typically brought in for.
What can Allscripts do that Annalise.ai cannot?
Allscripts covers Electronic Health Records, Practice Management, Population Health, Care Coordination. Annalise.ai covers Annalise Enterprise CXR, Annalise Enterprise CTB, Triage and notification, Worklist reprioritisation.

Answered from the vendors’ own pages

Allscripts: How do I obtain pricing information for Veradigm solutions?

Veradigm does not publish pricing on their website. Interested buyers must contact a Veradigm Account Executive directly or request a demo to discuss pricing and licensing options tailored to their needs.

Source
Annalise.ai: How many findings are FDA cleared?

Around ten across chest X-ray and head CT, for triage and notification only. The model reports far more findings than that; the rest are not cleared in the United States.

Allscripts: What industries does Veradigm serve?

Veradigm serves four primary market segments: Healthcare Providers, Life Sciences companies, Health Plans and Payers, and Health IT Vendors. Each segment has specialized solutions.

Source
Annalise.ai: Is the European position different?

Yes. CE marking under the medical device regulation covers a broader decision support indication than the United States triage and notification clearances, so the same software is a different regulatory product depending on where you deploy it.

Allscripts: Is there a trial available for Veradigm solutions?

Veradigm offers the option to request a demo of their solutions, which is the primary way potential customers can evaluate the platform before making a purchasing decision.

Source
Annalise.ai: Does it diagnose?

No. In the United States it is a triage and notification device: it flags studies for earlier review, and the radiologist makes the diagnosis.

Annalise.ai: Is Annalise.ai becoming Harrison.ai?

The critical care offering is now marketed under the Harrison.ai name. Ask the vendor to name the contracted product explicitly before signing a multi-year deal.

Share

Related pages

More on Allscripts

More on Annalise.ai

Keep looking

Other head to heads